Literature DB >> 7911472

The expression of proliferation-dependent antigens during the lifespan of normal and progeroid human fibroblasts in culture.

I R Kill1, R G Faragher, K Lawrence, S Shall.   

Abstract

Normal human fibroblasts display a limited lifespan in culture, which is due to a steadily decreasing fraction of cells that are able to proliferate. Using antibodies that react with antigens present in proliferating cells only, in an indirect immunofluorescence assay, we have estimated the fraction of proliferating cells in cultures of normal human fibroblasts. Furthermore, we have estimated the rate of decline in the fraction of proliferating cells during the process of cellular ageing by application of the assay to normal human fibroblasts throughout their lifespan in culture. Werner's Syndrome is an autosomal recessive disease in which individuals display symptoms of ageing prematurely. Werner's Syndrome fibroblasts display a reduced lifespan in culture compared with normal human fibroblasts. Like normal human fibroblasts, the growth of Werner's Syndrome fibroblasts is characterised by a decreasing fraction of cells reacting with the proliferation-associated antibodies throughout their lifespan in culture. However, the rate of loss of proliferating cells in Werner's Syndrome fibroblasts during the process of cellular ageing is accelerated 5- to 6-fold compared with the rate determined for normal human fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911472     DOI: 10.1242/jcs.107.2.571

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  15 in total

1.  Chromosome territory positioning of conserved homologous chromosomes in different primate species.

Authors:  Laia Mora; Inma Sánchez; Montserrat Garcia; Montserrat Ponsà
Journal:  Chromosoma       Date:  2006-04-11       Impact factor: 4.316

Review 2.  Cellular senescence: unravelling complexity.

Authors:  João F Passos; Cedric Simillion; Jennifer Hallinan; Anil Wipat; Thomas von Zglinicki
Journal:  Age (Dordr)       Date:  2009-12

3.  The effects of physiological adaptations to calorie restriction on global cell proliferation rates.

Authors:  Matthew D Bruss; Airlia C S Thompson; Ishita Aggarwal; Cyrus F Khambatta; Marc K Hellerstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-02-01       Impact factor: 4.310

Review 4.  Progeroid syndromes: probing the molecular basis of aging?

Authors:  D Kipling; R G Faragher
Journal:  Mol Pathol       Date:  1997-10

5.  Association of pKi-67 with satellite DNA of the human genome in early G1 cells.

Authors:  J M Bridger; I R Kill; P Lichter
Journal:  Chromosome Res       Date:  1998-01       Impact factor: 5.239

6.  Cellular Werner phenotypes in mice expressing a putative dominant-negative human WRN gene.

Authors:  L Wang; C E Ogburn; C B Ware; W C Ladiges; H Youssoufian; G M Martin; J Oshima
Journal:  Genetics       Date:  2000-01       Impact factor: 4.562

7.  What determines the switch between atrophic and neovascular forms of age related macular degeneration? - the role of BMP4 induced senescence.

Authors:  Danhong Zhu; Xuemei Deng; Jing Xu; David R Hinton
Journal:  Aging (Albany NY)       Date:  2009-08-12       Impact factor: 5.682

8.  Structure and function of the human Werner syndrome gene promoter: evidence for transcriptional modulation.

Authors:  L Wang; K E Hunt; G M Martin; J Oshima
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

9.  Quantitative model of cell cycle arrest and cellular senescence in primary human fibroblasts.

Authors:  Sascha Schäuble; Karolin Klement; Shiva Marthandan; Sandra Münch; Ines Heiland; Stefan Schuster; Peter Hemmerich; Stephan Diekmann
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

10.  Autophagy-independent senescence and genome instability driven by targeted telomere dysfunction.

Authors:  Florie A Mar; Jayanta Debnath; Bradley A Stohr
Journal:  Autophagy       Date:  2015       Impact factor: 13.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.